a b s t r a c t TDP-43 is a discriminative protein that is found as intracellular aggregations in the neurons of the cerebral cortex and spinal cord of patients with amyotrophic lateral sclerosis (ALS); however, the mechanisms of neuron loss and its relation to the aggregations are still unclear. In this study, we generated a useful model to produce TDP-43 aggregations in the motor cortex using in utero electroporation on mouse embryos. The plasmids used were full-length TDP-43 and C-terminal fragments of TDP-43 (wild-type or M337V mutant) tagged with GFP. For the full-length TDP-43, both wild-type and mutant, electroporated TDP-43 localized mostly in the nucleus, and though aggregations were detected in embryonic brains, they were very rarely observed at P7 and P21. In contrast, TDP-43 aggregations were generated in the brains electroporated with the C-terminal TDP-43 fragments as previously reported in in vitro experiments. TDP-43 protein was distributed diffusely-not only in the nucleus, but also in the cytoplasm-and the inclusion bodies were ubiquitinated and included phosphorylated TDP-43, which reflects the human pathology of ALS. This model using in utero electroporation of pathogenic genes into the brain of the mouse will likely become a useful model for studying ALS and also for evaluation of agents for therapeutic purpose, and may be applicable to other neurodegenerative diseases, as well.
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Introduction
Amyotrophic lateral sclerosis (ALS) is a paralytic and fatal disorder caused by motor neuron degeneration in the brain and spinal cord. Familial ALS is represented in only 5-10% of all ALS patients, and most cases are sporadic. In familial ALS, mutations in superoxide dismutase 1 (SOD1), the TAR DNA-binding protein of 43 kDa (TARDBP, TDP-43), the fused in sarcoma protein (FUS, also known as the translocated in liposarcoma protein (TLS)), and UBQLN2, which encodes the ubiquitin-like protein ubiquilin 2, and the expansion of a hexanucleotide repeat in gene C9orf72, and in many other genes were reported (Deng et al., 2011; DeJesus-Hernandez et al., * Corresponding author at: 1-1-1 Tennoudai, Tsukuba, Ibaraki 305 8575, Japan. 2011). Although some mechanisms (Robberecht and Philips, 2013) , such as RNA editing deficiency, are suggested (Takuma et al., 1999) , the detailed pathogenic mechanisms of familial and sporadic ALS remain unknown.
TDP-43 is a nuclear factor functioning in RNA processing, and has a 414-amino-acid protein with two RNA recognition motifs (RRM1 and RRM2) and a carboxyl-terminal glycine-rich domain (Lagier-Tourenne et al., 2010; Lee et al., 2011) . This protein is identified as the major deposited protein in inclusion bodies in the brains of both familial and sporadic ALS, as well as frontotemporal lobar degeneration (FTLD) (Arai et al., 2006; Giordana et al., 2010; Mori et al., 2008) . There are many mutations in TDP-43 (TARDBP) even in the sporadic cases (Mackenzie et al., 2010) . In neuropathological examinations of ALS patients' neurons, TDP-43 is found in neuronal cytoplasmic inclusions, dystrophic neurites, and neuronal intranuclear inclusions. Three types of inclusions are found in ALS, namely, skein-like inclusions, round inclusions, and dot-like inclusions (Arai et al., 2006; Giordana et al., 2010; Mori et al., 2008) . The major disease-specific findings in ALS and FTLD include abnormal ubiquitination and phosphorylation of TDP-43, sarcosyl-insoluble TDP-43 inclusions, truncated 20-25 kDa TDP-43 C-terminal
